Standard stepwise therapy for overactive bladder (OAB) begins with conservative therapies such as lifestyle interventions and behavioral approaches. Medications—anticholinergics or beta-3 agonists—are ...

Medtech companies are increasingly investing in neuromodulation to treat UUI, which is estimated to impact 20% of adults ...

Women treated with antimuscarinics for overactive bladder syndrome are more likely to be diagnosed with depression after treatment onset than overactive bladder patients not treated with the ...

The American Urologic Association advises caution in the use of anticholinergic medications to treat older or frail adults with OAB. Despite an increased risk of cognitive decline associated with ...

Women with overactive bladder are frequently frustrated with treatment, which leads to discontinuation of therapy. Asynchronous telehealth visits keep women engaged in follow-up care, accelerates ...

A new study suggests that more women are being prescribed beta-3 agonists over anticholinergics for the treatment of overactive bladder (OAB), suggesting that more clinicians may be choosing this ...

—Maybe, say the results of a UK meta-analysis, which found some patients to benefit from the alternative approach. Considering the side effects of certain OAB medications and poor adherence, it’s ...

Results are from a meta-analysis of 33 trials involving 35,939 patients with overactive bladder. Overactive bladder treatment using antimuscarinic drugs increases the risks for urinary tract infection ...

Credit: Getty Images. The American Urologic Association advises caution in the use of anticholinergic medications to treat older or frail adults with OAB. Despite an increased risk of cognitive ...

Overactive bladder is a long-term condition that won’t go away on its own and may worsen if a person does not get treatment. The condition can be caused by issues in how the brain and bladder ...